Facetten
Zugriff
Einrichtung
Medientyp
- Text 51
Karte
Erscheinungsjahr
Autor/in
- Weisel, Katja
- Moreau, Philippe 7
- Goldschmidt, Hartmut 6
- Bokemeyer, Carsten 5
- Cavo, Michele 5
- alle zeigen
Sprache
51 Einträge gefunden
-
Health-related quality-of-life results from the phase 3 OPTIMISMM study: pomalidomide, bortezomib, and low-dose dexamethasone versus bortezomib and low-dose dexamethasone in relapsed or refractory multiple myeloma
- Weisel, Katja
- Dimopoulos, Meletios
- Moreau, Philippe
- Yagci, Munci
- Larocca, Alessandra
- Kanate, Abraham S
- Vural, Filiz
-
Relative efficacy of treatment options in transplant-ineligible newly diagnosed multiple myeloma:results from a systematic literature review and network meta-analysis
- Ramasamy, Karthik
- Dhanasiri, Sujith
- Thom, Howard
- Buchanan, Vanessa
- Robinson, Suzanne
- D'Souza, Vijay K
- Weisel, Katja
-
Intensive Care Outcomes of Patients after High Dose Chemotherapy and Subsequent Autologous Stem Cell Transplantation: A Retrospective, Single Centre Analysis
- Karagiannis, Panagiotis
- Sänger, Lena
- Alsdorf, Winfried
- Weisel, Katja
- Fiedler, Walter
- Kluge, Stefan
- Wichmann, Dominic
-
MOR202, a novel anti-CD38 monoclonal antibody, in patients with relapsed or refractory multiple myeloma: a first-in-human, multicentre, phase 1-2a trial
- Raab, Marc S
- Engelhardt, Monika
- Blank, Antje
- Goldschmidt, Hartmut
- Agis, Hermine
- Blau, Igor W
- Einsele, Hermann
-
Carfilzomib, dexamethasone, and daratumumab versus carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma (CANDOR): results from a randomised, multicentre, open-label, phase 3 study
- Dimopoulos, Meletios
- Quach, Hang
- Mateos, Maria-Victoria
- Landgren, Ola
- Leleu, Xavier
- Siegel, David
- Weisel, Katja
-
-
-
Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial
- Richardson, Paul G
- Oriol, Albert
- Beksac, Meral
- Liberati, Anna Marina
- Galli, Monica
- Schjesvold, Fredrik
- Lindsay, Jindriska
-
Ixazomib-Thalidomide-Dexamethasone for induction therapy followed by Ixazomib maintenance treatment in patients with relapsed/refractory multiple myeloma
- Ludwig, Heinz
- Poenisch, Wolfram
- Knop, Stefan
- Egle, Alexander
- Schreder, Martin
- Lechner, Daniel
- Hajek, Roman
-
-
Rationale and design of the German-speaking myeloma multicenter group (GMMG) trial HD6: a randomized phase III trial on the effect of elotuzumab in VRD induction/consolidation and lenalidomide maintenance in patients with newly diagnosed myeloma
2019 - Forschungsinformationssystem des UKE - frei zugänglich